Startups

March Biosciences logo

March Biosciences

Develops CAR-T cell therapies for cancers with limited treatment options, including a CD5-targeted program for T-cell malignancies.

Team

Aaron VernonChief Manufacturing Officer
Alice BexonActing CMO
Gurpreet RatraChief Business Officer
Maksim MamonkinCo-Founder and Scientific Advisory Board Chair
Nebojsa MilovicChief Technical Officer
Sarah HeinCEO and Co-Founder
Steve HaesshaeferHead of Clinical Operations
Tory LakeHead of Regulatory

Investments

$—Unknown dateModi Ventures